Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tapping away period pain: emotional freedom techniques put to the test

NCT ID NCT07658859

Symptom relief Sponsor: Ataturk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Emotional Freedom Techniques (EFT), a therapy that combines tapping on acupressure points with focused thoughts, can reduce pain intensity, pain-related worrying, and emotional distress in nursing students who suffer from painful periods. Participants are randomly assigned to receive a guided EFT session during their period or to continue their usual coping methods. The goal is to see if this simple, non-drug approach can provide relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Emotional Freedom Techniques (EFT)
What this could lead to
If effective, EFT could offer a safe, drug-free option for managing period pain and its emotional toll.
What could go wrong
This is a small, early-stage study in a specific group (nursing students), so results may not apply to others. The effect may be due to placebo or attention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 92 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being enrolled in a nursing program, * Being 18 years of age or older * Having had a regular menstrual cycle within the last six months * Experiencing primary dysmenorrhea during the last three menstrual cycles * Reporting moderate to severe pain according to the Visual Analog Scale (VAS: 4-10) * Voluntary participation in the study * Providing written informed consent Exclusion Criteria: * Having a diagnosed gynecological disease that may cause secondary dysmenorrhea (endometriosis, adenomyosis, uterine fibroids, pelvic inflammatory disease, etc.) * Having chronic pain syndrome * Receiving regular treatment or taking psychiatric medication due to a psychiatric diagnosis * Applying another pharmacological or non-pharmacological intervention that may affect pain perception during the research process, * Taking the course Obstetrics, Gynecology and Women's Health Nursing • Receiving/having received emotional freedom technique training, * Having previously received training in this technique or regularly using it * Having a cognitive or sensory problem that prevents communication or completing data collection forms * Not completing the application protocol * Incomplete completion of data collection forms * Wishing to withdraw from the research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary dysmenorrhea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Primary dysmenorrhea

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.